Related Experiment Video
Updated: Jul 18, 2026
Use of an Eight-arm Radial Water Maze to Assess Working and Reference Memory Following Neonatal Brain Injury
Published on: December 4, 2013
Auditory processing and learning/memory following erythropoietin administration in neonatally hypoxic-ischemic
Melissa M McClure1, Steven W Threlkeld, R Holly Fitch
1Department of Psychology, Behavioral Neuroscience Division, University of Connecticut, Unit 1020, 806 Babbidge Rd., Storrs, CT 06269-1020, USA.
Insights
Erythropoietin (Epo) administration protected against brain damage and behavioral deficits in a rat model of neonatal Hypoxia-Ischemia (HI) injury. Epo shows promise for preventing neurological impairments in infants following birth complications.
Area of Science:
- Neuroscience
- Developmental Biology
- Pharmacology
Background:
- Hypoxia-Ischemia (HI) is a frequent birth complication.
- HI can lead to long-term language, auditory, and learning impairments.
- Early brain injury impacts neurodevelopmental outcomes.
Purpose of the Study:
- To evaluate Erythropoietin (Epo) efficacy in mitigating HI-induced neuropathology and behavioral deficits.
- Investigate dose-dependent protective effects of Epo (300 or 1000 U/kg) in a rat model.
- Assess Epo's impact on auditory processing and learning/memory functions.
Main Methods:
- Neonatal rats (postnatal day 7) underwent HI injury induction.
- Epo or saline was administered intraperitoneally post-HI.
- Auditory processing, spatial learning, and associative learning were assessed behaviorally.
Main Results:
- Both Epo doses (300 and 1000 U/kg) significantly improved behavioral outcomes post-HI.
- Epo-treated rats demonstrated enhanced performance in auditory processing tasks.
- Epo administration improved spatial and associative learning/memory in the Morris water maze.
Conclusions:
- Epo treatment offers significant neuroprotection against HI-induced impairments.
- Findings support Epo's potential as a therapeutic agent for neonatal brain injury.
- Epo's established clinical use in pediatrics supports further investigation for HI treatment.
Background:
Hypoxia-ischemia (HI) is a common injury arising from prematurity/complications at birth and is associated with later language, auditory, and learning impairments.
Objective:
To investigate the efficacy of two doses (300 or 1000 U/kg) of Erythropoietin (Epo) in protecting against neuropathological and behavioral impairments associated with HI injury in rats.
Methods:
HI injury (right carotid artery cauterization and 120 min of 8% O(2)) was induced on postnatal day 7 (P7) and Epo or saline was administered i.p. immediately following the procedure. Auditory processing and learning/memory were assessed throughout development.
Results:
Both doses of Epo provided behavioral protection following HI injury. Rats given 300 or 1000 U/kg of Epo performed significantly better than HI animals on a short duration complex auditory processing procedure, on a spatial Morris water maze assessing spatial learning/reference memory, and a non-spatial water maze assessing associative learning/reference memory.
Conclusions:
Given Epo's extant clinical use (FDA approved for pediatric patients with anemia secondary to prematurity), the current results add to a growing body of literature supporting the use of Epo as a potential protective agent for neurological and behavioral impairments following early HI injury in infants.
